Tower Research Capital LLC TRC Increases Position in Corteva, Inc. (NYSE:CTVA)

Tower Research Capital LLC TRC boosted its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 34.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 45,225 shares of the company's stock after purchasing an additional 11,565 shares during the period. Tower Research Capital LLC TRC's holdings in Corteva were worth $2,576,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in CTVA. World Investment Advisors LLC purchased a new stake in shares of Corteva during the third quarter valued at $319,000. Wilmington Savings Fund Society FSB grew its stake in Corteva by 247.9% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 44,080 shares of the company's stock worth $2,591,000 after acquiring an additional 31,411 shares in the last quarter. Franklin Resources Inc. increased its position in shares of Corteva by 6.1% during the third quarter. Franklin Resources Inc. now owns 14,788,607 shares of the company's stock worth $860,746,000 after acquiring an additional 856,007 shares during the period. 1ST Source Bank boosted its holdings in shares of Corteva by 1.9% in the third quarter. 1ST Source Bank now owns 19,195 shares of the company's stock valued at $1,128,000 after purchasing an additional 367 shares during the period. Finally, JPMorgan Chase & Co. grew its stake in Corteva by 6.7% in the third quarter. JPMorgan Chase & Co. now owns 4,605,608 shares of the company's stock worth $270,764,000 after purchasing an additional 288,885 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.

Corteva Price Performance

Shares of CTVA stock traded down $0.21 during trading hours on Friday, reaching $61.50. The company had a trading volume of 1,803,138 shares, compared to its average volume of 3,314,685. Corteva, Inc. has a 12-month low of $50.01 and a 12-month high of $66.24. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. The company has a market capitalization of $42.01 billion, a price-to-earnings ratio of 47.67, a PEG ratio of 1.68 and a beta of 0.73. The stock has a fifty day moving average of $60.77 and a 200-day moving average of $60.35.

Corteva (NYSE:CTVA - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, equities analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.11%. The ex-dividend date was Monday, March 3rd. Corteva's dividend payout ratio (DPR) is 52.71%.

Analyst Upgrades and Downgrades

A number of research analysts have commented on CTVA shares. BNP Paribas raised shares of Corteva to a "hold" rating in a research report on Monday, February 10th. Oppenheimer lifted their price target on Corteva from $70.00 to $72.00 and gave the company an "outperform" rating in a report on Friday, February 7th. Citigroup upped their price objective on Corteva from $69.00 to $74.00 and gave the stock a "buy" rating in a research note on Wednesday, January 29th. Barclays boosted their target price on shares of Corteva from $62.00 to $64.00 and gave the stock an "equal weight" rating in a report on Tuesday, January 21st. Finally, Wells Fargo & Company raised their price target on shares of Corteva from $67.00 to $73.00 and gave the company an "overweight" rating in a report on Tuesday, January 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Corteva presently has a consensus rating of "Moderate Buy" and an average price target of $68.13.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 26,560 shares of the business's stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the sale, the insider now directly owns 11,347 shares in the company, valued at $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.14% of the company's stock.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.